In the structure of the title compound, C25H29N6O + · Cl - ·1.69H2O, the irbesartan cation adopts tautomeric form A. The structure is stabilized by systems of hydrogen bonds forming ribbons along the ac diagonal, inter-linked by sets of weaker hydrogen bonds involving the solvent water.
2-Butyl-4-oxo-3-([2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl)-3-aza-1-azoniaspiro[4.4]non-1-ene chloride 1.69-hydrate (irbesartan hydrochloride 1.69-hydrate) / G. BARTOLUCCI; B. BRUNI; M. DI VAIRA; V. GIANNELLINI. - In: ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE. - ISSN 1600-5368. - ELETTRONICO. - 63:(2007), pp. o1529-o1531. [10.1107/S1600536807008951]
2-Butyl-4-oxo-3-([2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl)-3-aza-1-azoniaspiro[4.4]non-1-ene chloride 1.69-hydrate (irbesartan hydrochloride 1.69-hydrate)
BARTOLUCCI, GIAN LUCA;BRUNI, BRUNO;DI VAIRA, MASSIMO;GIANNELLINI, VALERIO
2007
Abstract
In the structure of the title compound, C25H29N6O + · Cl - ·1.69H2O, the irbesartan cation adopts tautomeric form A. The structure is stabilized by systems of hydrogen bonds forming ribbons along the ac diagonal, inter-linked by sets of weaker hydrogen bonds involving the solvent water.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
